Updated - NSW Health Public Hospital Supply Contract
Open PDF
| Stock | Algorae Pharmaceuticals Ltd (1AI.ASX) |
|---|---|
| Release Time | 2 Jul 2026, 9:47 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Algorae Pharmaceuticals Secures NSW Health Contract
Key Points
- NSW Health contract awarded to AlgoraeRx
- Initial term of three years with two one-year extensions
- Strategically significant but no immediate financial impact expected
Full Summary
Algorae Pharmaceuticals Ltd, through its division AlgoraeRx, has been awarded a contract by NSW Health for the supply of a pharmaceutical product to public hospitals and other eligible customers. The contract, which is not exclusive, has an initial term of three years with two optional one-year extensions. AlgoraeRx was selected following a competitive tender process, satisfying NSW Health's requirements. The product's identity is commercial-in-confidence, and onboarding and rollout are underway with first supply expected in Q4 2026. While the contract is strategically significant, Algorae Pharmaceuticals does not expect it to have a material impact on its revenue in the current calendar year.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In